BioTechne Corp (TECH)
(Delayed Data from NSDQ)
$80.36 USD
+3.85 (5.03%)
Updated Sep 19, 2024 03:59 PM ET
After-Market: $80.43 +0.07 (0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Brokerage Reports
Bio-Techne Corp [TECH]
Reports for Purchase
Showing records 1 - 20 ( 189 total )
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 091424
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 21224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 12224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 1224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Life Science Technology: Today''s FDA Approvals Setting CGT Record - Tool Beneficiary Overview
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 12223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 111123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 11123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
1Q24 - China Weakness, but Core Growth Persists
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 102123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 101123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 10123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 92123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 91123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
LT Guide Reflects Reality but Upside Potential
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 9123
Provider: Stock Traders Daily
Analyst: Research Department